Drosophila as a starting point for developing therapeutics for the rare disease Duchenne Muscular Dystrophy

Progress into developing therapeutics for rare diseases can be accelerated for those diseases that can be modeled in genetically tractable organisms. Here we comment on one disease, Duchenne Muscular Dystrophy (DMD), modeled in Drosophila that brought together disparate lines of research toward the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantoja, Mario, Ruohola-Baker, Hannele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Addendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932943/
https://www.ncbi.nlm.nih.gov/pubmed/25002997
http://dx.doi.org/10.4161/rdis.24995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932943/
https://www.ncbi.nlm.nih.gov/pubmed/25002997
http://dx.doi.org/10.4161/rdis.24995

Ejemplares similares